Clinical Trial Update: Use of Combined Measurements of Serum Infliximab and Anti-infliximab Antibodies in the Treatment of Patients With Crohns Disease Failing Infliximab Therapy [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial update assessing whether combining measurements of serum infliximab and anti-infliximab antibodies helps treat Crohn's disease in patie…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Crohn Disease

Drugs mentioned

• Infliximab (infliximab)

Snippet

Sponsor: Copenhagen University Hospital at Herlev | Conditions: Crohn's Disease | Phase 4 | Status: UNKNOWN